Aptose to Report Second Quarter 2022 Financial Results and Hold Conference Call on Tuesday, August 2, 2022
SAN DIEGO and TORONTO, July 19, 2022 -- Aptose Biosciences Inc. , a clinical-stage precision oncology company developing highly differentiated oral kinase inhibitors to treat hematologic...
Source: marketscreener.com